"Dattwyler R"[Author] - Search Results

Year	Number of Results
1987	1
1988	1
1990	1
1991	2
1993	1
1996	1
1997	1
2001	1
2003	1
2005	1
2009	1
2010	1
2022	0

1

Spirochetal infection of the central nervous system.

Coyle PK, Dattwyler R. Coyle PK, et al. Among authors: dattwyler r. Infect Dis Clin North Am. 1990 Dec;4(4):731-46. Infect Dis Clin North Am. 1990. PMID: 2277196 Review.

2

Response to meta-analysis of Lyme borreliosis symptoms.

Shapiro ED, Dattwyler R, Nadelman RB, Wormser GP. Shapiro ED, et al. Among authors: dattwyler r. Int J Epidemiol. 2005 Dec;34(6):1437-9; author reply 1440-3. doi: 10.1093/ije/dyi241. Epub 2005 Nov 30. Int J Epidemiol. 2005. PMID: 16319106 No abstract available.

3

Lymphocyte subsets in the neonates of preeclamptic mothers.

Baker DA, Hameed C, Tejani N, Thomas J, Dattwyler R. Baker DA, et al. Among authors: dattwyler r. Am J Reprod Immunol Microbiol. 1987 Aug;14(4):107-9. doi: 10.1111/j.1600-0897.1987.tb00129.x. Am J Reprod Immunol Microbiol. 1987. PMID: 2963550

4

Ventricular tachycardia associated with Lyme carditis.

Vlay SC, Dervan JP, Elias J, Kane PP, Dattwyler R. Vlay SC, et al. Among authors: dattwyler r. Am Heart J. 1991 May;121(5):1558-60. doi: 10.1016/0002-8703(91)90173-f. Am Heart J. 1991. PMID: 2017995 No abstract available.

5

Single-dose doxycycline for the prevention of Lyme disease.

Pontrelli L, Dattwyler R, Nachman S. Pontrelli L, et al. Among authors: dattwyler r. N Engl J Med. 2001 Nov 1;345(18):1348; author reply 1349-50. N Engl J Med. 2001. PMID: 11794160 No abstract available.

6

Modulation of natural killer cell activity by Borrelia burgdorferi.

Golightly M, Thomas J, Volkman D, Dattwyler R. Golightly M, et al. Among authors: dattwyler r. Ann N Y Acad Sci. 1988;539:103-11. doi: 10.1111/j.1749-6632.1988.tb31843.x. Ann N Y Acad Sci. 1988. PMID: 3056196 No abstract available.

7

Neurologic manifestations in children with North American Lyme disease.

Belman AL, Iyer M, Coyle PK, Dattwyler R. Belman AL, et al. Among authors: dattwyler r. Neurology. 1993 Dec;43(12):2609-14. doi: 10.1212/wnl.43.12.2609. Neurology. 1993. PMID: 8255465

8

Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment.

Wormser GP, Shapiro ED, Halperin JJ, Porwancher RB, O'Connell S, Nadelman RB, Strle F, Radolf JD, Hovius JW, Baker PJ, Fingerle V, Dattwyler R. Wormser GP, et al. Among authors: dattwyler r. Minerva Med. 2009 Apr;100(2):171-2. Minerva Med. 2009. PMID: 19390504 No abstract available.

9

Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis.

del Rio B, Fuente JL, Neves V, Dattwyler R, Seegers JF, Gomes-Solecki M. del Rio B, et al. Among authors: dattwyler r. Vaccine. 2010 Sep 24;28(41):6714-22. doi: 10.1016/j.vaccine.2010.07.084. Epub 2010 Aug 8. Vaccine. 2010. PMID: 20699130 Free PMC article.

10

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.

Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, Dattwyler R, Chandler B. Krupp LB, et al. Among authors: dattwyler r. Neurology. 2003 Jun 24;60(12):1923-30. doi: 10.1212/01.wnl.0000071227.23769.9e. Neurology. 2003. PMID: 12821734 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results